QUAD Investment Management logo

QUAD Investment Management

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

QUAD Investment Management is an investment firm.

Investor Profile

QUAD Investment Management has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series D rounds (top funding stages).
  • Majority of deals are located in United States, South Korea, Singapore.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.

Stage Focus

  • Series B (30%)
  • Series C (20%)
  • Series D (20%)
  • Post Ipo Equity (10%)
  • Series E (10%)
  • Series A (10%)

Country Focus

  • United States (70%)
  • South Korea (20%)
  • Singapore (10%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Business Development
  • Mhealth
  • Pharmaceutical
  • Software
  • Health Care
  • Oncology
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does QUAD Investment Management frequently co-invest with?

Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 2
Shinhan Private Equity
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Pilot House Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Sarissa Capital Management
North America, Connecticut, United States, Greenwich
Co-Investments: 2
FM
Europe, Stirling, United Kingdom, Stirling
Co-Investments: 2
Jazz Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
Neuberger Berman
North America, New York, United States, New York
Co-Investments: 2

Which angels does QUAD Investment Management often collaborate with?

David Baszucki
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by QUAD Investment Management?

NeoCannBio

Seoul, Seoul-t'ukpyolsi, South Korea

NeoCannBio offers natural product processing for natural goods and has created a hemp and medical cannabis cannabinoid library.

BiopharmaCannabisHealth Care
Series BSep 26, 2023
Amount Raised: $7,383,838
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series EApr 25, 2023
Amount Raised: $106,500,000
Good Food For Good

Seoul, Seoul-t'ukpyolsi, South Korea

Good Food For Good operates as a food & lifestyle brand company.

Food and BeverageLifestyle
Series ADec 5, 2022
Amount Raised: $22,982,213
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Post Ipo EquityDec 6, 2021
Amount Raised: $125,000,000
Akili Interactive Labs

Boston, Massachusetts, United States

Akili Interactive Labs Provides Healthcare Treatments.

BiotechnologyHealth CareMedicalNeuroscienceService IndustryTherapeutics
Series DMay 26, 2021
Amount Raised: $110,000,000
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Series DDec 8, 2020
Amount Raised: $80,000,000
4D Molecular Therapeutics

Emeryville, California, United States

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

BiotechnologyGenetics
Series CJun 16, 2020
Amount Raised: $75,000,000
Curiox Biosystems

Singapore, Central Region, Singapore

Curiox Biosystems is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore.

BiotechnologyMedical Device
Series BOct 16, 2019
Amount Raised: $15,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series CSep 23, 2019
Amount Raised: $16,600,000
Oncorus

Cambridge, Massachusetts, United States

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

BiotechnologyMedicalOncologyTherapeutics
Series BAug 21, 2019
Amount Raised: $79,500,000

Find More Investors Like QUAD Investment Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

QUAD Investment Management | Pipeseed